Asemblis
About
Asemblis is developing biofabricated tissue models for obesity and metabolic disease preclinical research. Our approach combines biofabrication, fluidics, and automation to bring biological complexity, scalability, and operational simplicity together in a single platform, enabling R&D teams to generate more predictive, human-relevant data before clinical trials.
Advanced Biomanufacturing and Ecosystem Enablers
Scale-up and manufacturing of complex therapiesTechnological integration and cross-sectoral transfer
Representatives
CEO at Asemblis
Asemblis